Maze Therapeutics, Inc. Balance Sheet
Maze Therapeutics, Inc.'s total assets for Q3 2025 were $422.06M, an increase of 39.05% from the previous quarter. MAZE total liabilities were $42.62M for the fiscal quarter, a 3.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.